PBM Reform Podcast: Follow the Money, Expose the System, Demand Accountability
APCI’s Greg Reybold and 3 Axis Advisors’ Antonio Ciaccia examine PBM savings claims, drug pricing research, and the financial incentives behind prescription costs.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
APCI’s Greg Reybold and 3 Axis Advisors’ Antonio Ciaccia examine PBM savings claims, drug pricing research, and the financial incentives behind prescription costs.
Federal audits raise questions about whether TRICARE receives all negotiated pharmacy savings and whether military families benefit from policies favoring mail order.
An audit’s scope determines what it can uncover. Pharmacy payment comparisons need to capture what happens after a prescription is filled.
Iowa’s PBM reform fight shows how pharmacists can help shape policy, build legislative support, and defend reforms after they become law.
Four federal audits reveal how negotiated savings failed to reach health plans and why APCI is calling for enforceable payment rules.
TRICARE’s shrinking pharmacy network raises questions about patient choice, rural access, and whether current standards truly measure meaningful pharmacy access.
H.R. 6610 has cleared committee with overwhelming bipartisan support. Now independent pharmacy needs Congress to keep the Pharmacists Fight Back Act moving.
The Pharmacists Fight Back Act applies to one federal health program. If successful, it could become a model for broader pharmacy benefit manager reform efforts.
The House Oversight Committee advanced the Pharmacists Fight Back Act on a bipartisan 40–2 vote, moving H.R. 6610 one step closer to consideration by the full House.
APCI’s Greg Reybold called for greater transparency and independent oversight of the TRICARE pharmacy program during a Senate hearing. Watch key exchanges on Express Scripts, community pharmacy access, mail-order costs, and the need for an independent audit.